Wang Chuyan, Yu Miao, Che Yilin, Du Ruyi, Xu Yaoyao, Niu Junqi, Chi Xiumei
Core Facility of the First Hospital of Jilin University, Changchun, Jilin, China.
School of Public Health, Jilin University, Changchun, Jilin, China.
Front Cell Infect Microbiol. 2025 Aug 22;15:1661155. doi: 10.3389/fcimb.2025.1661155. eCollection 2025.
Diabetes and viral hepatitis, particularly hepatitis B (HBV) and hepatitis C (HCV), are significant global health burdens with complex interconnections. This review discusses the molecular mechanisms linking viral hepatitis to diabetes, focusing on inflammatory pathways, oxidative stress, and epigenetic modifications. Key findings highlight the role of STAT3 in promoting insulin resistance and β-cell apoptosis, the impact of ER stress and NOX-mediated oxidative stress on metabolic dysfunction, and the influence of epigenetic changes such as DNA methylation and histone acetylation on glucose homeostasis. These interconnected pathways provide insights into the pathogenesis of diabetes in hepatitis patients and suggest potential therapeutic targets for managing these co-occurring conditions. Future research directions include exploring the synergistic effects of these pathways and leveraging advanced technologies for personalized treatment strategies.
糖尿病和病毒性肝炎,尤其是乙型肝炎(HBV)和丙型肝炎(HCV),是具有复杂相互联系的重大全球健康负担。本综述讨论了将病毒性肝炎与糖尿病联系起来的分子机制,重点关注炎症途径、氧化应激和表观遗传修饰。主要发现突出了信号转导和转录激活因子3(STAT3)在促进胰岛素抵抗和β细胞凋亡中的作用、内质网应激和NADPH氧化酶介导的氧化应激对代谢功能障碍的影响,以及DNA甲基化和组蛋白乙酰化等表观遗传变化对葡萄糖稳态的影响。这些相互关联的途径为深入了解肝炎患者糖尿病的发病机制提供了思路,并提示了管理这些并存疾病的潜在治疗靶点。未来的研究方向包括探索这些途径的协同作用,以及利用先进技术制定个性化治疗策略。